Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Amazon
AMZN
5
Jefferies Financial
JEF
CA Stock MarketDetailed Quotes
APLI Appili Therapeutics Inc
- 0.030
- +0.005+20.00%
15min DelayMarket Closed Apr 25 16:00 ET
3.64MMarket Cap-1.00P/E (TTM)
0.030High0.030Low18.00KVolume0.030Open0.025Pre Close540.00Turnover0.05052wk High0.02%Turnover Ratio121.27MShares0.02552wk Low-0.03EPS TTM3.20MFloat Cap1.890Historical HighLossP/E (Static)106.83MShs Float0.025Historical Low-0.03EPS LYR0.00%Amplitude--Dividend TTM-0.27P/B1Lot Size--Div YieldTTM
Appili Therapeutics Inc News
Appili Therapeutics Brief: Adds New Subject Matter Listed in the U.S. Food and Drug Administration's Orange Book
Appili Therapeutics Brief: Says New Patents "Provide Additional Composition of Matter and Methods of Use Claims, Strengthening Protection For Liquid Oral Taste-masked Reformulation"
Appili Therapeutics Announces New Patents Granted for Commercial Stage Asset LIKMEZ
Appili President and CEO, Don Cilla to Join Aditxt CEO, Amro Albanna for Aditxt Weekly Update on April 4, 2025
Express News | Appili Therapeutics Inc - Four New Funding Proposals, Totalling US$117.5 Mln, Submitted for Review
Appili Therapeutics Announces Submission of U.S. Federal Government Funding Proposals and Provides Corporate and Aditxt Transaction Update
Express News | Aditxt's Subsidiary Adimune Successfully Completes Preclinical Efficacy and Safety Studies for Its Immune Modulation Therapeutic Adi Platform, Advancing Toward First-in-Human Clinical Trials
Appili Therapeutics Announces Receipt of Final Court Order for Arrangement With Aditxt, Inc.
Appili Therapeutics Inc: INTERIM MDA EN
Appili Therapeutics Inc: INTERIM FINANCIAL STATEMENTSREPORT EN
Express News | Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025
Express News | Aditxt Provides Update on Equity Line of Credit, Atm Usage, and Outstanding Number of Shares
Express News | Aditxt Acquisition Target Evofem Biosciences Secures Investor Support Through Voting Agreements for Merger With Aditxt's Subsidiary Adifem
Aditxt's Target Acquisition Appili Therapeutics Announces Alignment With FDA on Development Requirements for ATI-1801 Topical Antiparasitic Product NDA Submission
Appili Therapeutics Announces "Alignment" With FDA on ATI-1801 Development Requirements
Express News | Sylvia Hermina Joins Aditxt’s Board of Directors, Elevating Leadership With Broader Perspectives
Appili Therapeutics – Press Release Correction
Express News | Aditxt’s Acquisition Target Appili Therapeutics Will Hold a Special Meeting of Shareholders on November 6, 2024, to Vote on the Transaction and Secure Appili’s Shareholder Approval
Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders
Appili Therapeutics Brief: Says Definitive Agreement With Aditxt, If Approved by Appili Shareholders, "Provides Significant Premium to Shareholders and Resources to Advance Key Programs"
Market Insights
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.
Unlock Now
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs